Italian Law Compelling Off-Label Use May Spread In EU, Worries Pharma
This article was originally published in The Pink Sheet Daily
Executive Summary
Moves by Italian and French lawmakers to compel doctors to prescribe drugs off-label in indications where there are approved medicines available already effectively will bypass the EU’s rigorous regulatory framework and put patients at risk, and pharma warns the trend could spread in the region.